Back
Alkermes PLC Vs. Monopar Therapeutics Industry Stock Comparison
Sell
41
ALKS
Alkermes PLC
Last Price:
$33.53
Seasonality Move:
0.79%
Buy
53
MNPR
Monopar Therapeutics
Last Price:
$39.00
Seasonality Move:
-14.17%
Sell
41
Alkermes PLC (ALKS)
is a Sell
Is Alkermes PLC a Buy, Sell or Hold?
-
The current Alkermes PLC [ALKS] share price is $33.53. The Score for ALKS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ALKS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $41.39. The Score for MNPR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALKS Stock Price Chart
What is Alkermes PLC's stock price today?
-
The Alkermes PLC share price today is $33.53The current trend is moderately bearish and ALKS is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $41.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
ALKS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.17 | Buy |
Relative Strength Index (14 RSI): | 46.07 | Sell |
Chaikin Money Flow: | -1021510 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.81 - 35.09) | Sell |
Bollinger Bands (100): | (28.39 - 33.65) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.85 | Buy |
Relative Strength Index (14 RSI): | 58.68 | Buy |
Chaikin Money Flow: | 12278 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.98 - 39.9) | Buy |
Bollinger Bands (100): | (19.38 - 39.44) | Buy |
ALKS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.14 | Sell |
20-day SMA: | 34.25 | Sell |
50-day SMA: | 32.97 | Buy |
200-day SMA: | 28.77 | Buy |
8-day EMA: | 34.01 | Sell |
20-day EMA: | 34.06 | Sell |
50-day EMA: | 33.07 | Buy |
200-day EMA: | 29.87 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.11 | Buy |
20-day SMA: | 34.28 | Buy |
50-day SMA: | 37.57 | Buy |
200-day SMA: | 16.87 | Buy |
8-day EMA: | 38.3 | Buy |
20-day EMA: | 36.79 | Buy |
50-day EMA: | 34.94 | Buy |
200-day EMA: | 21.55 | Buy |
Alkermes PLC Earnings Growth & ALKS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.02 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Alkermes PLC Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |